We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTB icon
401
M&T Bank
MTB
$36.8B
– –
-1,277
Closed -$257K
MTH icon
402
Meritage Homes
MTH
$5.17B
– –
-4,522
Closed -$298K
QUCY
403
Quantum Cyber N.V.
QUCY
$27.1M
– –
-775,263
Closed -$868K
NGD
404
DELISTED
New Gold Inc
NGD
– –
-32,070
Closed -$279K
NNVC icon
405
NanoViricides
NNVC
$40.7M
– –
-1,368,000
Closed -$1.55M
NPO icon
406
Enpro
NPO
$6.83B
– –
-1,337
Closed -$286K
NRG icon
407
NRG Energy
NRG
$28B
– –
-1,461
Closed -$233K
NVO
408
Novo Nordisk
NVO
$228B
– –
-336,000
Closed -$17.1M
NVT icon
409
nVent Electric
NVT
$24.8B
– –
-2,892
Closed -$295K
OBDC icon
410
Blue Owl Capital
OBDC
$5.55B
– –
-24,146
Closed -$300K
OTEX icon
411
Open Text
OTEX
$5.68B
– –
-7,335
Closed -$239K
OXY icon
412
Occidental Petroleum
OXY
$53.4B
– –
-13,976
Closed -$575K
PCTY icon
413
Paylocity
PCTY
$6.79B
– –
-2,719
Closed -$415K
PLMR icon
414
Palomar
PLMR
$3.56B
– –
-2,192
Closed -$295K
POOL icon
415
Pool Corp
POOL
$7.58B
– –
-3,073
Closed -$703K
PYPL icon
416
PayPal
PYPL
$50B
– –
-20,891
Closed -$1.22M
QRVO icon
417
Qorvo
QRVO
$7.37B
– –
-3,529
Closed -$298K
RBOT
418
DELISTED
Vicarious Surgical
RBOT
– –
-605,443
Closed -$1.31M
RNAM
419
DELISTED
Avidity Biosciences
RNAM
– –
-4,159
Closed -$300K
RSG icon
420
Republic Services
RSG
$69.1B
– –
-2,592
Closed -$549K
RVSNW icon
421
Rail Vision Ltd Warrant
RVSNW
$873K
– –
-136,187
Closed -$9.52K
SAIC icon
422
Saic
SAIC
$4.86B
– –
-7,961
Closed -$801K
SBUX icon
423
Starbucks
SBUX
$124B
– –
-549,805
Closed -$46.3M
SCI icon
424
Service Corp International
SCI
$11B
– –
-4,624
Closed -$361K
SE icon
425
Sea Limited
SE
$65.1B
– –
-27,400
Closed -$3.5M
15 16
17
18 19

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.